FASLG and neoplasm: NKs attack tumor cells directly by mechanisms such as release of lytic granules/granzymes and triggering receptor-mediated cell death via overexpression of death ligands like Fas ligand (FasL) or tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL).